Yourgene Health Plc YGEN.L Stock
Yourgene Health Plc Price Chart
Yourgene Health Plc YGEN.L Financial and Trading Overview
Yourgene Health Plc stock price | 0.52 GBP |
Previous Close | 0.24 GBP |
Open | 0.23 GBP |
Bid | 0.23 GBP x 0 |
Ask | 0.24 GBP x 0 |
Day's Range | 0.23 - 0.24 GBP |
52 Week Range | 0.2 - 8 GBP |
Volume | 191.9K GBP |
Avg. Volume | 11.4M GBP |
Market Cap | 7.62M GBP |
Beta (5Y Monthly) | 0.616475 |
PE Ratio (TTM) | N/A |
EPS (TTM) | 0 GBP |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 1.1 GBP |
YGEN.L Valuation Measures
Enterprise Value | 17.24M GBP |
Trailing P/E | N/A |
Forward P/E | -0.013333333 |
PEG Ratio (5 yr expected) | 0.92 |
Price/Sales (ttm) | 0.25700095 |
Price/Book (mrq) | 6.666667 |
Enterprise Value/Revenue | 0.581 |
Enterprise Value/EBITDA | -6.225 |
Trading Information
Yourgene Health Plc Stock Price History
Beta (5Y Monthly) | 0.616475 |
52-Week Change | -96.75% |
S&P500 52-Week Change | 20.43% |
52 Week High | 8 GBP |
52 Week Low | 0.2 GBP |
50-Day Moving Average | 0.24 GBP |
200-Day Moving Average | 1.65 GBP |
YGEN.L Share Statistics
Avg. Volume (3 month) | 11.4M GBP |
Avg. Daily Volume (10-Days) | 7.05M GBP |
Shares Outstanding | 3.18B |
Float | 505.74M |
Short Ratio | N/A |
% Held by Insiders | 33.57% |
% Held by Institutions | 14.83% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor | 1:100 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | March 31, 2022 |
Most Recent Quarter (mrq) | September 30, 2022 |
Next Fiscal Year End | March 31, 2023 |
Profitability
Profit Margin | -27.55% |
Operating Margin (ttm) | -19.36% |
Gross Margin | 55.47% |
EBITDA Margin | -9.33% |
Management Effectiveness
Return on Assets (ttm) | -6.70% |
Return on Equity (ttm) | -27.064% |
Income Statement
Revenue (ttm) | 29.67M GBP |
Revenue Per Share (ttm) | 0.04 GBP |
Quarterly Revenue Growth (yoy) | -45.20% |
Gross Profit (ttm) | 21.37M GBP |
EBITDA | -2770000 GBP |
Net Income Avi to Common (ttm) | -8174000 GBP |
Diluted EPS (ttm) | -0.01 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 2.4M GBP |
Total Cash Per Share (mrq) | 0.003 GBP |
Total Debt (mrq) | 17.94M GBP |
Total Debt/Equity (mrq) | 68.93 GBP |
Current Ratio (mrq) | 1.367 |
Book Value Per Share (mrq) | 0.036 |
Cash Flow Statement
Operating Cash Flow (ttm) | -2870000 GBP |
Levered Free Cash Flow (ttm) | -294125 GBP |
Profile of Yourgene Health Plc
Country | United Kingdom |
State | N/A |
City | Manchester |
Address | Skelton House |
ZIP | M15 6SH |
Phone | 44 16 1669 8122 |
Website | https://www.yourgene-health.com |
Industry | Diagnostics & Research |
Sector(s) | Healthcare |
Full Time Employees | 253 |
Yourgene Health Plc, a molecular diagnostic company, researches, develops, and commercializes gene analysis techniques for prenatal screening and other applications in the United Kingdom, rest of Europe, and internationally. It develops in vitro diagnostic products, such as IONA Test, a non-invasive pre-natal test (NIPT) for Down's syndrome, Edwards' syndrome, and Patau's Syndrome in pregnant women; Cystic Fibrosis Screening tests; Rapid Aneuploidy Analysis, a confirmatory diagnostic test carried out after amniocentesi; and Recurrent Pregnancy Loss, a PCR assay for the routine diagnosis of the six most common chromosomes related to pregnancy loss, as well as DPYD genotyping products. The company also offers Ranger, a technology platform for sample size selection and enrichment; Elucigene DPYD assay, a PCR test to predict a patient's response to a chemotherapy treatment; and Clarigene SARS-CoV-2 CE-IVD, a PCR assay used for routine COVID-19 testing. In addition, it provides genomic services; sample preparation and analysis tools; and bioinformatics and software products, as well as extraction for DNA, RNA/miRNA, and nucleons; quantification; genotyping; gene expression; methylation; and microarray services for clinical research organizations. The company was formerly known as Premaitha Health PLC and changed its name to Yourgene Health Plc in November 2018. Yourgene Health Plc was incorporated in 2000 and is headquartered in Manchester, the United Kingdom.
Q&A For Yourgene Health Plc Stock
What is a current YGEN.L stock price?
Yourgene Health Plc YGEN.L stock price today per share is 0.52 GBP.
How to purchase Yourgene Health Plc stock?
You can buy YGEN.L shares on the LSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Yourgene Health Plc?
The stock symbol or ticker of Yourgene Health Plc is YGEN.L.
Which industry does the Yourgene Health Plc company belong to?
The Yourgene Health Plc industry is Diagnostics & Research.
How many shares does Yourgene Health Plc have in circulation?
The max supply of Yourgene Health Plc shares is 31.93M.
What is Yourgene Health Plc Price to Earnings Ratio (PE Ratio)?
Yourgene Health Plc PE Ratio is 0.00000000 now.
What was Yourgene Health Plc earnings per share over the trailing 12 months (TTM)?
Yourgene Health Plc EPS is 0 GBP over the trailing 12 months.
Which sector does the Yourgene Health Plc company belong to?
The Yourgene Health Plc sector is Healthcare.